These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18722605)

  • 1. Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome.
    Kalra P; Bansal B; Nag P; Singh JK; Gupta RK; Kumar S; Rathore RK; Bhatia V; Bhatia E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1437-40. PubMed ID: 18722605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes.
    Cho LW; Jayagopal V; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2009 May; 46(Pt 3):218-21. PubMed ID: 19389885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome.
    Lecke SB; Mattei F; Morsch DM; Spritzer PM
    Fertil Steril; 2011 May; 95(6):2044-9. PubMed ID: 21419406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.
    Carmina E; Bucchieri S; Mansueto P; Rini G; Ferin M; Lobo RA
    Fertil Steril; 2009 Apr; 91(4 Suppl):1332-5. PubMed ID: 18455165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal adiposity and the polycystic ovary syndrome.
    Escobar-Morreale HF; San Millán JL
    Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.
    Karadeniz M; Erdoğan M; Tamsel S; Zengi A; Alper GE; Cağlayan O; Saygili F; Yilmaz C
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):231-5. PubMed ID: 18393129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hand functions in women with polycystic ovary syndrome.
    Soyupek F; Guney M; Eris S; Cerci S; Yildiz S; Mungan T
    Gynecol Endocrinol; 2008 Oct; 24(10):571-5. PubMed ID: 19012100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polycystic ovary syndrome and insulin resistance].
    Puder J; Pralong F
    Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.
    Amini M; Horri N; Farmani M; Haghighi S; Sattari G; Pornaghshband Z; Aminorroaya A
    Gynecol Endocrinol; 2008 Aug; 24(8):423-7. PubMed ID: 18850378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of polycystic ovarian syndrome and relationship with ghrelin in adolescents.
    Ozgen IT; Aydin M; Guven A; Aliyazicıoglu Y
    J Pediatr Adolesc Gynecol; 2010 Oct; 23(5):285-9. PubMed ID: 20537572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries.
    Kaushal R; Parchure N; Bano G; Kaski JC; Nussey SS
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):322-8. PubMed ID: 15008997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo.
    Rajkhowa M; Brett S; Cuthbertson DJ; Lipina C; Ruiz-Alcaraz AJ; Thomas GE; Logie L; Petrie JR; Sutherland C
    Biochem J; 2009 Mar; 418(3):665-71. PubMed ID: 19053948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.